Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi-Aventis lifts outlook as Q3 profit rises
TMCnet
Sunday, October 31, 2010 - 11:10am
tags:
Sanofi, earnings
New Data Analyses on CONCERTA Pediatric Treatment Include Insight on Handwriting Performance and Attention in ADHD
Pipeline Review
Sunday, October 31, 2010 - 11:04am
tags:
Concerta, Ortho-McNeil-Janssen, ADHD
Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II Phase III Study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
Pipeline Review
Sunday, October 31, 2010 - 11:02am
tags:
Forrest, Almirall, COPD, aclidinium bromide
Sun Pharma consolidated Q2 net up at Rs 504-cr
istockanalyst
Sunday, October 31, 2010 - 11:00am
tags:
Sun Pharma
Savient: Risky but Promising Small Cap
Seeking Alpha
Sunday, October 31, 2010 - 10:58am
tags:
Savient, gout, Oxandrin, Krystexxa
Amicus Therapeutics Agreement with GSK - Call Transcript
Seeking
Sunday, October 31, 2010 - 10:56am
tags:
GSK, Amicus Therapeutics
Salix Pharmaceuticals Previews Data Slated for Presentation at 61st Annual Meeting of the American Association for the Study of Liver Diseases
MarketWatch
Saturday, October 30, 2010 - 1:17pm
tags:
Salix, Xifaxan, hepatic encephalopathy
Piramal Healthcare Plans to Acquire Some More Companies
Top News
Saturday, October 30, 2010 - 1:14pm
tags:
Piramal Healthcare
Merck KGaA sells women's health business to Teva for €285 million news
domain-b
Saturday, October 30, 2010 - 1:11pm
tags:
Merck KGaA, Teva Pharmaceuticals, Theramex
Lotus Pharma receives Chinese approval to initiate phase-I trials of asthma drug R-bambuterol
PharmaBiz
Saturday, October 30, 2010 - 1:09pm
tags:
Lotus, R-bambuterol hydrochloride, asthma
Pfizer ranks at the top in philanthropy
The Day
Saturday, October 30, 2010 - 1:07pm
tags:
Pfizer
Dr Reddys Labs a market performer: Karvy Stock Broking
MoneyControl
Saturday, October 30, 2010 - 1:06pm
tags:
Dr Reddy's
Taro Pharmaceutical net zooms by 93% in Q3
PharmaBiz
Saturday, October 30, 2010 - 1:05pm
tags:
Taro, earnings
AstraZeneca sues Watson Pharma over generic Crestor
PharmaBiz
Saturday, October 30, 2010 - 1:04pm
tags:
AstraZeneca, Watson Pharmaceuticals, Crestor
Evotec and APEIRON Biologics Build Pain Alliance
Benzinga
Saturday, October 30, 2010 - 1:02pm
tags:
Evotec, Apeiron, pain management, Downstream Regulatory Element Antagonistic Modulator
Novartis drug Afinitor® approved by FDA as first medication for children and adults with a benign brain tumor associated with tuberous sclerosis
PharmPro
Saturday, October 30, 2010 - 1:00pm
tags:
Novartis, Afinitor, tuberous sclerosis, brain tumors
7 Pharma Stocks Near 52-Week Highs
Motley Fool
Saturday, October 30, 2010 - 12:43pm
tags:
JNJ, Novartis, Merck, Abbott Laboratories, AstraZeneca, Novo Nordisk
Vertex, Merck Drugs Help More with Faster Cure for Hepatitis C in Studies
Bloomberg
Saturday, October 30, 2010 - 12:41pm
tags:
Vertex Pharmaceuticals, Merck, hepatitis C, Telaprevir, Roche, Pegasys
Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates In Treatment-Failure and Treatment-Naïve Adult Patients with Chronic Hepatitis C Genotype 1 Compared to Control
Yahoo/BusinessWire
Saturday, October 30, 2010 - 12:39pm
tags:
Merck, hepatitis C, Boceprevir
Cost Cuts Help Merck to Avert Revenue Losses
NY Times
Saturday, October 30, 2010 - 12:37pm
tags:
Merck, Vioxx

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.